(Total Views: 106)
Posted On: 08/22/2022 12:55:50 PM
Post# of 74551

$SLRX News Article - Salarius Pharmaceuticals Adds Two Mayo Clinic Sites to its Ongoing Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing's Sarcoma and FET-Rearranged Sarcomas https://marketwirenews.com/news-releases/sala...06736.html


My Twitter: WhyteStocks